Skip to content

Clinical trials

Skin Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Neoplasms Country / region: South Korea Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20141
20191
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Pfizer2
Iovance Biotherapeutics, Inc.1
Medicenna Therapeutics, Inc.1
Revolution Medicines, Inc.1
Turnstone Biologics, Corp.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Neoplasms8
Melanoma7
Neoplasms5
Carcinoma, Renal Cell3
Colorectal Neoplasms3
Neoplasm Metastasis3
Ovarian Neoplasms3
Uterine Cervical Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Ovarian Epithelial2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.